VIENNA LINC

Life-science Insights, News & Context

Our Mission — Who we are

We help great science reach the people it matters to.

Vienna is one of Europe's leading life-science hubs. Its researchers, start-ups, and companies turn science into real-world impact — but that work too often stays within the lab or the field it came from.

Vienna LINC is a non-profit initiative that helps close this gap. We link research to the people it affects: putting findings into context, explaining why they matter, and connecting the scientists behind them with the wider public and the scientific community.

We work alongside institutional press offices and communications teams — as a complement, not a competitor — drawing on hands-on experience in public and press media as well as research. Through articles, interviews, and context pieces, we communicate life-science innovation in the detail it deserves, and strengthen Vienna's standing as a life-science hub.

Work with us

For researchers and communications teams.

Have a finding, project, or start-up that deserves a wider audience? We help you turn it into a clear story — finding the angle, putting the science in context, and drafting posts, articles, or interviews that hold up to scrutiny.

We work alongside institutional press offices and communications teams as an extra pair of hands, not a replacement — preparing material they can use and respecting the structures already in place. There's no cost to collaborate.

Get in touch
Latest

Insights, news & context

Short posts and writings from Vienna's life sciences appear here.

Analysis · Colorectal Cancer

Colorectal Cancer: New Strategy Could Make Immunotherapy More Effective

Checkpoint inhibitors help only a small proportion of patients with metastatic colorectal cancer. A team led by the Medical University of Vienna has found an immune brake in the cells around the tumour, and switching it off made immunotherapy work in a preclinical model.

Read the article →August 2026
Analysis · Cardiac Organoids

Cardiac Organoid Platform Co-Developed in Vienna Validated for Early Drug Development and Derisking

Cardioids grew out of a question about human heart development at IMBA. The platform is now a commercial kit, validated by an external contract research organization that is also a partner of the manufacturer.

Read the article →August 2026
Analysis · Metaproteomics

Vienna Scientists Set a New Standard for Investigating the Functions of our Microbiome

Metaproteomics can reveal what gut microbes actually do, but only if you measure it right. A Vienna team benchmarked five PASEF strategies head-to-head and produced the practical selection guide the field was missing.

Read the article →August 2026
Explainer · How we work

How Vienna LINC works

We gather the stories and background from Vienna's labs and start-ups, put them in context, and turn them into ready-to-use briefings — we don't report, we make it easy to report. We handle distribution, while the press offices, groups and founders keep full sign-off. A partner to the teams already doing great work, not a competitor.

vienna-linc.orgJuly 2026
News · Launch

LINC goes online

Gregor Mendel's laws of inheritance went unrecognised for 37 years — a brilliant example of how important science communication can be. That gap between discovery and the wider world is exactly why we exist. Vienna LINC launches as a non-profit initiative that helps scientists connect: with each other, and with the public.

vienna-linc.orgJuly 2026
Get in touch

Contact & suggestions

Questions, collaborations, press enquiries — or a Vienna life-science story, lab, or start-up worth covering? Send us a message.